Member Exclusive
First patient dosed in Japanese iPSC Parkinson’s trial
A patient in his 50s received iPSC-derived nerve cells to supplement dopamine-emitting neurons.
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.
No comments yet.